Table 4.
Variables | Multivariable* | Interaction | |
---|---|---|---|
QTc difference (95% CI), ms | P | P** | |
Serum calcium and potassium in one model | |||
Total calcium, per 1 SD decrease | + 0.12 (−0.008, 0.25) | 0.07 | 0.29 |
Potassium, per 1 SD decrease | + 0.14 (0.04, 0.23) | 0.004 | |
Ionized calcium and potassium in one model | |||
Ionized calcium, per 1 SD decrease | + 0.21 (0.10, 0.32) | < 0.001 | 0.18 |
Potassium, per 1 SD decrease | + 0.13 (0.04, 0.22) | 0.003 | |
Serum calcium and magnesium in one model | |||
Serum calcium, per 1 SD decrease | + 0.12 (−0.02, 0.25) | 0.08 | 0.19 |
Magnesium, per 1 SD decrease | −0.02 (− 0.15, 0.12) | 0.82 | |
Ionized calcium and magnesium in one model | |||
Ionized calcium, per 1 SD decrease | + 0.21 (0.10, 0.31) | < 0.001 | 0.87 |
Magnesium, per 1 SD decrease | + 0.01 (−0.13, 0.14) | 0.91 | |
Serum potassium and magnesium in one model | |||
Serum potassium, per 1 SD decrease | + 0.13 (0.04, 0.23) | 0.006 | 0.84 |
Magnesium, per 1 SD decrease | −0.02 (−0.15, 0.12) | 0.79 |
*Includes main exposures (calcium, potassium, or magnesium), age, sex, ethnicity, Charlson comorbidity index, non-dialysis systolic blood pressure, left ventricular mass index, and use of beta-blocker, renin-angiotensin-aldosterone system blockade, cinacalcet, and QT-prolonging medication. Model with ionized calcium also includes serum pH
**Interaction between calcium and potassium tested in a separate model